Objective: Panel-based sequencing is widely used to measure tumor mutational burden (TMB) in clinical trials and is ready to enter routine diagnostics. However, cut-off points to distinguish “TMB-high
Summary This metadata record provides details of the data supporting the claims of the related manuscript: “Panels and models for accurate prediction of tumor mutation burden in tumor sampl
Summary This metadata record provides details of the data supporting the claims of the related manuscript: “Panels and models for accurate prediction of tumor mutation burden in tumor samples”. The re
